Invesco Ltd. Myriad Genetics Inc Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Myriad Genetics Inc stock. As of the latest transaction made, Invesco Ltd. holds 557,781 shares of MYGN stock, worth $8.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

557,781

Previous 608,447 8.33%

Holding current value

$8.49 Million

Previous $14.9 Million 2.58%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$23.97 - $28.6 $1.21 Million - $1.45 Million	-50,666 Reduced 8.33%	557,781 $15.3 Million
Q2 2024 Aug 13, 2024	SELL	$17.98 - $25.47 $39,663 - $56,186	-2,206 Reduced 0.36%	608,447 $14.9 Million
Q1 2024 May 14, 2024	SELL	$17.59 - $23.59 $1.63 Million - $2.19 Million	-92,767 Reduced 13.19%	610,653 $13 Million
Q4 2023 Feb 12, 2024	SELL	$13.91 - $21.32 $753,309 - $1.15 Million	-54,156 Reduced 7.15%	703,420 $13.5 Million
Q3 2023 Nov 13, 2023	BUY	$15.99 - $23.22 $761,443 - $1.11 Million	47,620 Added 6.71%	757,576 $12.2 Million
Q2 2023 Aug 11, 2023	BUY	$17.56 - $23.76 $5.04 Million - $6.81 Million	286,785 Added 67.77%	709,956 $16.5 Million
Q1 2023 May 12, 2023	SELL	$15.26 - $23.75 $5.87 Million - $9.13 Million	-384,570 Reduced 47.61%	423,171 $9.83 Million
Q4 2022 Feb 13, 2023	BUY	$14.51 - $20.99 $5.49 Million - $7.94 Million	378,134 Added 88.02%	807,741 $11.7 Million
Q3 2022 Nov 14, 2022	SELL	$18.21 - $27.88 $243,613 - $372,978	-13,378 Reduced 3.02%	429,607 $8.2 Million
Q2 2022 Aug 15, 2022	SELL	$16.45 - $25.88 $3.57 Million - $5.61 Million	-216,807 Reduced 32.86%	442,985 $8.05 Million
Q1 2022 May 16, 2022	SELL	$22.67 - $28.01 $2.97 Million - $3.67 Million	-130,960 Reduced 16.56%	659,792 $16.6 Million
Q4 2021 Feb 14, 2022	SELL	$24.13 - $32.63 $373,363 - $504,883	-15,473 Reduced 1.92%	790,752 $21.8 Million
Q3 2021 Nov 15, 2021	BUY	$29.97 - $36.66 $1.21 Million - $1.48 Million	40,327 Added 5.27%	806,225 $26 Million
Q2 2021 Aug 17, 2021	SELL	$25.39 - $32.61 $5.47 Million - $7.02 Million	-215,403 Reduced 21.95%	765,898 $23.4 Million
Q1 2021 May 17, 2021	BUY	$19.92 - $31.6 $9.53 Million - $15.1 Million	478,591 Added 95.2%	981,301 $29.9 Million
Q4 2020 Feb 16, 2021	BUY	$12.16 - $19.77 $23,006 - $37,404	1,892 Added 0.38%	502,710 $9.94 Million
Q3 2020 Nov 16, 2020	SELL	$11.25 - $14.75 $5.11 Million - $6.7 Million	-453,961 Reduced 47.55%	500,818 $6.53 Million
Q2 2020 Aug 14, 2020	BUY	$10.69 - $16.49 $968,588 - $1.49 Million	90,607 Added 10.48%	954,779 $10.8 Million
Q1 2020 May 15, 2020	BUY	$9.78 - $29.53 $3.57 Million - $10.8 Million	365,365 Added 73.25%	864,172 $12.4 Million
Q4 2019 Feb 14, 2020	SELL	$20.93 - $35.1 $26.8 Million - $44.9 Million	-1,278,540 Reduced 71.94%	498,807 $13.6 Million
Q3 2019 Nov 14, 2019	SELL	$22.08 - $47.08 $1.74 Million - $3.71 Million	-78,786 Reduced 4.24%	1,777,347 $50.9 Million
Q2 2019 Aug 14, 2019	BUY	$22.67 - $35.0 $6.92 Million - $10.7 Million	305,143 Added 19.67%	1,856,133 $51.6 Million
Q1 2019 May 15, 2019	SELL	$26.93 - $34.7 $2.51 Million - $3.24 Million	-93,347 Reduced 5.68%	1,550,990 $51.5 Million
Q4 2018 Feb 14, 2019	BUY	$27.23 - $45.56 $44.8 Million - $74.9 Million	1,644,337 New	1,644,337 $47.8 Million

Others Institutions Holding MYGN

# of Institutions

253

Shares Held

90.9M

Call Options Held

100K

Put Options Held

34K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.23B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account